Sanyou Super-Trillion Innovative Antibody Drug Discovery Platform Announced
yahoo.com
finance
2022-06-03 00:00:00

SHANGHAI, June 2, 2022 /PRNewswire/ -- Sanyou Biopharmaceuticals officially launched STAL (Super-Trillion Antibody Libraries) on June 3, 2022, which is a super-trillion innovative antibody drug discovery platform of Sanyou's own intellectual property.

Developed by Sanyou after seven years of continuous innovation and independent R&D, STAL represents a significant breakthrough over the previous generation of the sub-trillion innovative antibody discovery platforms. The STAL discovery platform integrates nine categories of super-trillion innovative antibody libraries with the overall library capacity up to 10 trillion.
